# Utilization of TEG to Monitor Rivaroxaban Activity

> **NCT02651909** · — · COMPLETED · sponsor: **Matthew Neal MD** · enrollment: 100 (actual)

## Conditions studied

- Anemia
- Venous Thrombosis

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT02651909
- **Lead sponsor:** Matthew Neal MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-07-07
- **Final completion:** 2019-11-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651909, "Utilization of TEG to Monitor Rivaroxaban Activity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02651909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*